Decoy Therapeutics (DCOY) Total Liabilities (2014 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Total Liabilities of $4.5 million for Q1 2026, up 99.6% year-over-year from $2.3 million in Q1 2025, and down 12.03% quarter-over-quarter from $5.2 million in Q4 2025.
Decoy Therapeutics (DCOY) Total Liabilities (2014 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Total Liabilities for 13 consecutive years, with $4.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 99.6% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (up 99.6% YoY), while the FY2025 annual figure was $5.2 million, up 241.94% from the prior year.
- Total Liabilities slipped to $4.5 million in Q1 2026 per DCOY's latest filing, from $5.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $5.2 million in Q4 2025 and bottomed at $934581.0 in Q3 2024.
- Historically, Total Liabilities has averaged $2.6 million across 5 years, with a median of $2.3 million in 2025.
- Annual changes were most pronounced in 2024 — Total Liabilities sank 72.55% — and 2025, when it jumped 241.94%.
- Decoy Therapeutics' Total Liabilities stood at $4.3 million in 2022, then sank by 69.55% to $1.3 million in 2023, then advanced by 16.32% to $1.5 million in 2024, then surged by 241.94% to $5.2 million in 2025, then dropped by 12.03% to $4.5 million in 2026.
- Business Quant data shows DCOY's Total Liabilities at $4.5 million in Q1 2026, $5.2 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 10.03 Bn |
| 10 | Decoy Therapeutics | 1.73 Mn | 1.73 Mn | - | 4.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.68 Mn |
| Mar 31, 2026 | 4.55 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 2.22 Mn |
| Mar 31, 2025 | 2.28 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 934,581.00 |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 2.32 Mn |
| Jun 30, 2023 | 3.64 Mn |
| Mar 31, 2023 | 4.50 Mn |
| Dec 31, 2022 | 4.27 Mn |
| Sep 30, 2022 | 3.11 Mn |
| Jun 30, 2022 | 2.77 Mn |
| Mar 31, 2022 | 2.09 Mn |
| Dec 31, 2021 | 2.11 Mn |
| Sep 30, 2021 | 1.61 Mn |